https://www.selleckchem.com/pr....oducts/ory-1001-rg-6
Background Obesity is a world-wide epidemic and it is a risk factor for type 2 diabetes (T2D). Few randomized controlled studies have compared the 2 most common surgical procedures, Roux-en-Y gastric bypass (RYG and sleeve gastrectomy (SG) in the treatment of obese patients with T2D. Objectives To compare diabetes remission rates (glycosylated hemoglobin ≤6.0%, without diabetes medications) in obese T2D patients (body mass index, 35-5 undergoing RYGB or SG. Setting Three University Hospital clinics and 1 Regional Hospital i
Mi piace
Commento
Condividi
